China Health Labs & Diagnostics Ltd. announces conference call to discuss results of the first quarter ended March 31, 2012 and
23 May 2012 - 11:00PM
PR Newswire (Canada)
-- Financial Results for the First Quarter Ended March 31, 2012 to
be released on May 30, 2012 -- BioFinance presentation on May 30,
2012 TSX-V: CHO OTCQX: CHLBF www.chinahealthlabs.com
TORONTO, May 23, 2012 /CNW/ - China Health Labs & Diagnostics
Ltd. ("China Health" or the "Company") , is pleased to announce
that after market close on Wednesday, May 30, 2012, it will be
releasing its results for the first quarter ended March 31, 2012,
and will be hosting an investor conference call on Thursday, May
31, 2012 at 10:00 am (Eastern Time). The purpose of this conference
call will be to provide investors with an update of the first
quarter results of the Company. Representing China Health on
the conference call will be: Mr. Shiping (Wilson) Yao, President
and Chief Executive Officer Ms. Judyanna Chen, Chief Financial
Officer Mr. Kim Oishi, Member of the Board of Directors Mr. Chao
Zhang, Vice President, Finance Following the update, a question and
answer session will be held. To participate, the dial-in
instructions are as follows: DATE: Thursday, May 31, 2012 TIME:
10:00 am, Eastern Time Participant Dial-In Number(s): North America
Toll-Free Dial-In Number: 1 (888) 231-8191 For Toronto and
International Callers: 1 (647) 427-7450 A taped replay will be
available from 1:00 pm Eastern Time on May 31, 2012 to 11:59 pm
Eastern Time on June 14, 2012. Taped Replay Toll Free Number: 1
(855) 859-2056 Taped Replay Local Dial-in Numbers: (778) 371-8506
(416) 849-0833 (514) 807-9274 (403) 451-9481 (613) 667-0035 (902)
455-3955 Taped Replay Password: 83319568 The Company is also
pleased to announce that Mr. Kim Oishi, a Director of the Company,
will provide a corporate update on China Health at BioFinance 2012
on Wednesday, May 30, 2012 at 9:40 a.m. Eastern Time. The
conference will be held at the St. Andrew's Club & Conference
Centre at 150 King Street West in Toronto, Ontario. BioFinance is
the leading investor conference in Canada for the life sciences
industry. This event brings together key industry players
interested in investment opportunities and issues affecting
companies in the life sciences sector. Presenting companies span a
range of industries including biologics, medical devices, drug
delivery, vaccines, and diagnostics. About China Health Labs &
Diagnostics Ltd. China Health, operating in China as the Biochem
Group, is a leading diagnostic lab solution provider for the public
healthcare industry in China. The Company develops and sells
Biochem Group branded and third-party medical diagnostic products
and services to diagnostic facilities in China. Customers include
large urban hospitals, rural hospitals, Chinese military and rescue
operations, the Beijing government and third-party distributors.
The Company intends to continue its growth by focusing its efforts
on expanding its sales network in three areas where it provides
proprietary solutions, has limited competition and which are
supported by Chinese government policies and budgets: BK Clinlab
total lab solutions for rural hospitals and clinics, POCT solutions
for military and emergency rescue services, and food safety
solutions for large cities in China. In 2011, China Health
increased its revenues by 35% to $45.6 million, and increased its
installed base of BK Clinlab total solution diagnostic labs ("BK
Clinlabs") from 210 at the start of 2011 to 833 rural
hospitals. In addition, the Company grew revenues from its
overall total lab solutions business by 99% from 2010, which
increased gross margins to 44% in 2011 as compared to 39% in 2010.
Neither TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release. FORWARD LOOKING INFORMATION This press release
contains forward-looking statements and information that are based
on the beliefs of management and reflect China Health's current
expectations. When used in this press release, the words
"estimate", "project", "belief", "anticipate", "intend", "expect",
"plan", "predict", "may" or "should" and the negative of these
words or such variations thereon or comparable terminology are
intended to identify forward-looking statements and
information. The forward-looking statements and information
in this press release includes information relating to the
expansion of the Company's business through its sales network in
areas where it has proprietary products, limited competition and
strong government support. The forward-looking information is
based on certain assumptions, which could change materially in the
future, including the assumption that the Company will be able to
expand its sales network and business. Such statements and
information reflect the current view of China Health with respect
to risks and uncertainties that may cause actual results to differ
materially from those contemplated in those forward-looking
statements and information. By their nature, forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or
achievements, or other future events, to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. Such factors include,
among others, the risk that the Company may not be able to expand
its business as expected through its sales network in any of the
areas in which it has proprietary products, limited competition and
strong government support. China Health cautions that the
foregoing list of material factors is not exhaustive. When
relying on China Health's forward-looking statements and
information to make decisions, investors and others should
carefully consider the foregoing factors and other uncertainties
and potential events. China Health has assumed a certain
progression, which may not be realized. It has also assumed
that the material factors referred to above will not cause such
forward-looking statements and information to differ materially
from actual results or events. However, the list of these
factors is not exhaustive and is subject to change and there can be
no assurance that such assumptions will reflect the actual outcome
of such items or factors. THE FORWARD-LOOKING INFORMATION CONTAINED
IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH
AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT
TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE
IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON
THIS INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY
ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY
PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE
LAWS. CHINA HEALTH LABS & DIAGNOSTICS CONTACT: Judyanna
ChenChief Financial OfficerChina Health Labs & Diagnostics
Ltd.T: (416) 865-3351Email: jchen@chinahealthlabs.comBabak
PedramInvestor RelationsTMX Equicom GroupT: (416) 815-0700 ext.
264Email: bpedram@equicomgroup.com
Copyright
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jul 2023 to Jul 2024